Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

IceCure (ICCM) Q3 2026 Earnings Call Transcript

U.S. sales surged 83% while operating losses widened for the period.

On the IceCure earnings call for Q3 2026, the company reported an 83% increase in U.S. sales as it expanded its commercial reach to 21 states. Total revenue for the period grew 26%, driven by increased physician adoption of the ProSense cryoablation system. Management emphasized the progress made in advancing the ChoICE post-marketing study, securing regulatory approval in China, and establishing a distribution agreement in the Netherlands.

Financial results showed an increase in operating loss to $12.9 million, attributed to investments in U.S. sales and ongoing clinical development activities. The company maintains $8.2 million in cash to support its growth strategy. The operator reminded participants that the call contained forward-looking statements subject to risks and uncertainties described in prior filings.

IceCure CEO Eyal Shamir began by highlighting the commercial momentum in the U.S., with total revenue increasing 26% year-over-year and U.S. sales up 83%, indicating the expansion of commercial activities and growing ProSense adoption. The company nearly doubled its U.S. commercial footprint, growing from 11 states to 21 states, by adding dedicated sales and marketing professionals in key regions and increasing physician engagement.

Shamir also discussed the ChoICE post-marketing study, which has now established three clinical sites and enrolled the first patients at two U.S. centers. Additionally, the company secured regulatory approval in China and an exclusive distribution agreement in the Netherlands, expanding ProSense's international market presence.

Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at fool.com →

More in Finance & Markets

Hafnia (HAFN) Q3 2026 Earnings Call Transcript

Hafnia spins out its TORM stake and rewrites its dividend policy.

  • Hafnia's CEO Soren Steenberg Jensen welcomed attendees to Q3 2026 earnings call
  • CFO Perry Van Echtelt presented $170.8 million net profit for Q3
  • EVP Soren Winther discussed market trends and product tankers' positive outlook

Impinj: 3 Key Takeaways for Long-Term Investors

Custom silicon and enterprise software have the potential to shift Impinj from point solutions to recurring platform revenue.

  • Impinj's endpoint integrated circuits revenue hits record quarterly levels
  • Manufacturing bottlenecks limit chip supply for Impinj
  • Wafer post-processing throughput to increase, boosting demand fulfillment

The Best Recession-Proof Consumer Stock to Buy With $1,000 Before 2027

This company often does even better in rough economies.

  • Costco Wholesale shows 11.2% total sales growth and 9.4% comparable sales growth in fiscal 2026 Q4
  • Retailer's membership model and lower gas prices drive sales during economic downturns
  • Costco announces $30 per share special dividend, up 30% year to date

Brinker: 3 Key Takeaways for Long-Term Investors

Remodel investments of $500K–$600K per location are expected to lift sales 3% to 5%, potentially helping to protect shareholder returns.

  • Brinker International reported $2.77 adjusted diluted EPS for Q1 2027
  • Same-store sales up 10% YoY, Chili's comp sales grew 6%
  • CEO Kevin Hochman highlights menu simplification and value platform

More from Wednesday 18 November →